Dr Marcy J Oppenheimer, MD | |
1150 Varnum St Ne, St. Catherine's Hall/1st Fl/rm 102, Washington, DC 20017-2104 | |
(202) 854-4812 | |
(202) 854-7825 |
Full Name | Dr Marcy J Oppenheimer |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 20 Years |
Location | 1150 Varnum St Ne, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023243581 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD040280 (District Of Columbia) | Primary |
207Q00000X | Family Medicine | D0075220 (Maryland) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Washington Hospital Center | Washington, DC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Health Services Inc | 4385541622 | 21 |
News Archive
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
If you're considering weight loss surgery, Beverly Hills Physicians has some very special thoughts for you as we approach Independence Day 2013. Serious obesity is never easy, but it can be especially difficult during the summer. Hikes, picnics, pool parties, even out of town vacations can be a lot more difficult if you're dealing with the discomfort and health problems that go with being extremely overweight. Still, sometimes the things that make us uncomfortable also spur us into action.
Gene Security Network (GSN) announced today that it has initiated enrollment for a prospective randomized trial in collaboration with Ferring Pharmaceuticals to evaluate the impact of GSN's advanced preimplantation genetic diagnosis (PGD) with Parental Support™ on pregnancy and implantation rates in IVF.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
A recent study finds that older drivers showed adaptive responses according to the amount of traffic in a driving scene when identifying road hazards.
› Verified 5 days ago
Entity Name | Providence Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669453809 PECOS PAC ID: 4385541622 Enrollment ID: O20031216000187 |
News Archive
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
If you're considering weight loss surgery, Beverly Hills Physicians has some very special thoughts for you as we approach Independence Day 2013. Serious obesity is never easy, but it can be especially difficult during the summer. Hikes, picnics, pool parties, even out of town vacations can be a lot more difficult if you're dealing with the discomfort and health problems that go with being extremely overweight. Still, sometimes the things that make us uncomfortable also spur us into action.
Gene Security Network (GSN) announced today that it has initiated enrollment for a prospective randomized trial in collaboration with Ferring Pharmaceuticals to evaluate the impact of GSN's advanced preimplantation genetic diagnosis (PGD) with Parental Support™ on pregnancy and implantation rates in IVF.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
A recent study finds that older drivers showed adaptive responses according to the amount of traffic in a driving scene when identifying road hazards.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Marcy J Oppenheimer, MD 1140 Varnum St Ne, Pmd Bldg/suite 103, Washington, DC 20017-2151 Ph: (202) 854-4090 | Dr Marcy J Oppenheimer, MD 1150 Varnum St Ne, St. Catherine's Hall/1st Fl/rm 102, Washington, DC 20017-2104 Ph: (202) 854-4812 |
News Archive
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
If you're considering weight loss surgery, Beverly Hills Physicians has some very special thoughts for you as we approach Independence Day 2013. Serious obesity is never easy, but it can be especially difficult during the summer. Hikes, picnics, pool parties, even out of town vacations can be a lot more difficult if you're dealing with the discomfort and health problems that go with being extremely overweight. Still, sometimes the things that make us uncomfortable also spur us into action.
Gene Security Network (GSN) announced today that it has initiated enrollment for a prospective randomized trial in collaboration with Ferring Pharmaceuticals to evaluate the impact of GSN's advanced preimplantation genetic diagnosis (PGD) with Parental Support™ on pregnancy and implantation rates in IVF.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
A recent study finds that older drivers showed adaptive responses according to the amount of traffic in a driving scene when identifying road hazards.
› Verified 5 days ago
Dr. Ryan J. Montoya, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1225 4th St Ne, Washington, DC 20002 Phone: 202-763-7394 | |
Dr. Rufina Nwanneka Odigwe, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2139 Georgia Ave Nw, Suite 3b, Washington, DC 20001 Phone: 202-865-1452 | |
Miss Aruna Selina Harduarsingh-permaul, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3020 14th St Nw, Washington, DC 20009 Phone: 202-745-4300 | |
Dr. Jewel Bynoe Osborne-wu, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1050 Connecticut Ave Nw Ste 500, Washington, DC 20036 Phone: 202-596-8891 Fax: 833-941-2357 | |
Dr. Lori A. Spoor, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 Columbia Rd Nw, Washington, DC 20009 Phone: 202-469-4699 Fax: 813-254-0230 | |
Dr. Keith Michael Egan, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 2nd St Ne, Washington, DC 20002 Phone: 202-346-3000 | |
Richard A Elion, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 14th Street Nw, Second Floor, Washington, DC 20009 Phone: 202-745-6142 Fax: 202-745-6152 |